Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial
Authors
Keywords
Alzheimer disease, add-on therapy, safety, NeuroAiD, delayed-start design
Journal
Journal of the American Medical Directors Association
Volume 23, Issue 3, Pages 379-386.e3
Publisher
Elsevier BV
Online
2021-11-29
DOI
10.1016/j.jamda.2021.10.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
- (2020) Narayanaswamy Venketasubramanian et al. CEREBROVASCULAR DISEASES
- A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
- (2018) Ruth Knight et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial
- (2018) A. Theadom et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia
- (2018) C. Widmann et al. Scientific Reports
- Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
- (2017) Rebecca F. Gottesman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effects of MLC901 on tau phosphorylation
- (2017) Wei Thye Lee et al. NEUROREPORT
- Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation
- (2017) Kenneth Hensley JOURNAL OF ALZHEIMERS DISEASE
- The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease
- (2017) Dong Liu et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Incidence of stroke and seizure in Alzheimer's disease dementia
- (2015) Michael Cook et al. AGE AND AGEING
- CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy
- (2015) Narayanaswamy Venketasubramanian et al. CEREBROVASCULAR DISEASES
- Positive effects of the traditional Chinese medicine MLC901 in cognitive tasks
- (2015) T. Lorivel et al. JOURNAL OF NEUROSCIENCE RESEARCH
- New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials
- (2015) Nishant Verma et al. Alzheimers Research & Therapy
- A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease
- (2015) Hong Liu-Seifert et al. PLoS One
- A Randomized trial to assess the long-term safety of NeuroAiD among Caucasian patients with acute ischemic stroke
- (2014) Reza Bavarsad shahripour et al. Chinese Journal of Integrative Medicine
- Therapeutic Efficacy of Neuro AiD™ (MLC 601), a Traditional Chinese Medicine, in Experimental Traumatic Brain Injury
- (2014) Ming-Che Tsai et al. Journal of Neuroimmune Pharmacology
- MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats
- (2014) H. Quintard et al. NEUROSCIENCE
- NeuroAiD: Properties for Neuroprotection and Neurorepair
- (2013) C. Heurteaux et al. CEREBROVASCULAR DISEASES
- NeuroAiD®(MLC601) and Amyloid Precursor Protein Processing
- (2013) Y.A. Lim et al. CEREBROVASCULAR DISEASES
- Alzheimer disease and risk of stroke: A population-based cohort study
- (2013) N.-F. Chi et al. NEUROLOGY
- Targeting Microglial KATPChannels to Treat Neurodegenerative Diseases: A Mitochondrial Issue
- (2013) Manuel J. Rodríguez et al. Oxidative Medicine and Cellular Longevity
- Chinese Medicine Neuroaid Efficacy on Stroke Recovery: A Double-Blind, Placebo-Controlled, Randomized Study
- (2013) C. L. H. Chen et al. STROKE
- Epidemiology of dementia in Asia: Insights on prevalence, trends and novel risk factors
- (2012) Joseree-Ann S. Catindig et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Activation of ATP-sensitive potassium channels as an element of the neuroprotective effects of the Traditional Chinese Medicine MLC901 against oxygen glucose deprivation
- (2012) H. Moha Ou Maati et al. NEUROPHARMACOLOGY
- Current and future treatments for Alzheimer’s disease
- (2012) Konstantina G. Yiannopoulou et al. Therapeutic Advances in Neurological Disorders
- A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease
- (2011) Richard Y Zhang et al. Clinical Trials
- What is the clinically relevant change on the ADAS-Cog?
- (2011) Anette Schrag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo
- (2010) C. Heurteaux et al. NEUROPHARMACOLOGY
- Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression
- (2009) Katherine J. Bangen et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Danqi Piantan Jiaonang Does Not Modify Hemostasis, Hematology, and Biochemistry in Normal Subjects and Stroke Patients
- (2008) Robert Gan et al. CEREBROVASCULAR DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started